Abstract: Cherry laurel (Prunus laurocerasus) fruits including phenolic and flavonoid contents are consumed as fresh, dried or prepared in marmalade and its leaves containing cyanogenic glycosides have healing activity of a well-known Anatolian folkloric remedy. Herein, Cherry laurel fruits were boiled in water for 2 h, then extracted with hexane, EtOAc, and BuOH successively. Antiproliferative activities of extracts were evaluated on HeLa (Human Cervix Carcinoma), HT29 (Human Colorectal Adenocarcinoma), C6 (Rat Brain Tumor Cells), and Vero (African Green Monkey Kidney) cell lines. All extracts exhibited slightly antiproliferative effects on various cancer cell lines at high concentration. We assessed the ability of extracts of cherry laurel fruit to devastate the membrane of cells. Results indicated that cherry laurel fruit extracts slightly destroys the cellular membrane in tumor cell lines at merely high concentrations. The results of this study does not support the efficacy of cherry laurel fruit extracts as an anticancer agent for cancer cells, but it suggests that cherry laurel fruit extracts may be used through reducing cytotoxicity, a potential adjuvant therapy to current chemotherapeutic agents. Fatty acids of hexane extract were also determined by GC-MS analysis and found out that linoleic acid, palmitic acid, and oleic acid were the major products.
INTRODUCTION
Plants have been used for treatment of various diseases from ancient times. Drug discovery and development process from natural products for confronting cancer has taken in the reasonable opportunity to achieve most new clinical applications of plant secondary metabolites and their derivatives (1, 2) . Cancer, occurring from heterogeneous diseases, is an excruciating illness and constitutes a significant medical problem. Despite promising progress in cancer epidemiology, cancer treatments are still not a good medicine without serious side effects, persistent drug resistance, and limited effect due to their ADME properties. Because of the need for more effective anticancer agents, natural products can be considered as suitable anticancer drug candidates. The natural products acquiring significance in the treatment of malady have contributed to health care worldwide through the isolation of bioactive compounds. Nearly 60% of drugs approved for cancer treatment are of natural source represent more than 50% of all the drugs in clinical use of the world (3, 4) . Several of them, namely taxol, camptothecin, and etoposide, are in clinical use all over the world. Many cancer research studies have been currently performed using extracts or isolate from plants in an effort to discover new therapeutic agents. Prunus laurocerasus (cherry laurel) is an evergreen species of cherry (Prunus), a shrub, which grows in southwestern Asia, and the Balkans. Ethanolic extraction of the fresh leaves of cherry laurel has a long traditional use as a homeopathic mother tincture. In Anatolian folk medicine, the leave extract is used in the therapy of coughs, hemorrhoids, eczemas, asthma, digestive system complaints as well as in the treatment of stomach ulcers (5-13). Traditionally it is also used in analgesic, antispasmodic, and sedative effects and furthermore, according to latest research, its aqueous and ethanolic extracts showed antifungal, antinociceptive and antiinflammatory activity without inducing any gastric lesions (5-13). Overall, leaves, fruit, and seed of cherry laurel are a valuable herbal medicine and used for various health complaints.
However, cherry laurel containing cyanogenic glycosides and amygdalin (Laetrile) can be toxic due to using dosage. According to our knowledge, there are no literature data on fruit of cherry laurel biological activities, especially the antiproliferative effect, to date.
The topic of this study was to assess pharmacological activity, cell cytotoxicity, and morphological alteration of valuable extracts from cherry laurel used traditionally in Anatolia. The antiproliferative activity of the extracts was conducted following the European Pharmacopoeia 8.0 protocol. According to this protocol, we investigated the antiproliferative and cytotoxic activity of fruits of cherry laurel in various solvent systems.
Aqueous (WEPL), hexane (HEPL), n-butanol (NBEPL) and ethyl acetate (EAEPL) extracts of cherry laurel (25 to 500 μg/mL) were investigated for their antiproliferative and cytotoxic activity against HT29, HeLa and C6 cancer cells and nontumorigenic Vero cells using ELISA BrdU Cell Proliferation assay and LDH cytotoxicity assay as well as morphological analysis.
MATERIALS and METHODS

Extraction
Cherry laurel fruits were boiled in water for 2 h then extracted with hexane, EtOAc, and n-butanol. After filtration and evaporation process, water, hexane, ethyl acetate, and nbutanol extracts were acquired to execute the antiproliferative activities (Table 1) . 
Preparation of cell culture
The anticancer potential of cherry laurel extracts was investigated on cancerous HT29 overnight. The final volume of the wells was set to 200 µL by medium. Cell proliferation assay was evaluated by ELISA BrdU methods as described previously (14) .
Calculation of IC50 and % inhibition
IC50 value is a concentration that inhibits half of the cells in vitro. The half maximal inhibitory concentration (IC50) of the test and control compounds was calculated using XLfit5 or excel spreadsheet and represent in µM at 95% confidence intervals. The proliferation assay results were expressed as the percent inhibition according to the following formula:
Cytotoxic activity assay
The cytotoxicity of the compounds and of 5 fluorouracil on HeLa, C6, HT29, and Vero cells was determined through a Lactate Dehydrogenase Assay Kit according to the manufacturer's instructions. Approximately 5 x 10 3 cells in 100 µL were placed into 96-well plates as triplicate and treated with IC50 (µg/mL) concentrations of test compounds at 37°C with 5% CO2 for 24 h. LDH activity was obtained by determining absorbance at 492 -630 nm using a microplate reader. The cytotoxicity assay results were noted as the percent cytotoxicity according to the following formula:
Cell imaging
Cells were plated in 96-well plates at a density of 5.000 cells per well and allowed 24 h.
IC50 values of the test compounds were administered and morphology alters of the cells were screened by phase contrast microscopy for 24 h every 6 h. Images of control and test compounds treated cells were photographed at the end of the process using a digital camera attached to an inverted microscope.
GC-MS analysis
A Perkin Elmer Clarus 500 instrument with FID flame ionizing detector (Rtx-2330) and column (30 m × 0.25 mm × 0.2 µm) was used for fatty acid analysis. Methyl esters of 37 fatty acids were applied for standards. Temperature of the detector was 250°C and injection temperature was 250°C. Injection splitting was 50/1 and carriage gas flow was 1 mL/min.
RESULTS and DISCUSSION
Antiproliferative effect of the Prunus laurocerasus extracts
Here, different extracts of cherry laurel were conducted for their antiproliferative activity against cancer and normal cell lines using 5FU as a control anticancer drug. The medicines from natural sources such as plant, algae or fungi are used in the management and treatment of various diseases including cancer (15) . For example, the fresh leaves of Prunus laurocerasus (British Pharmaceutical Codex, 1949) have been used as a flavoring agent (Cherry Pits, Extract (Prunus spp.)) in bad odor drugs and as a sedative for nausea or vomiting. With regard to the antiproliferative potential of cherry laurel, the data suggest that the growth of the cell lines was slightly inhibited by using cherry laurel extracts and among different extracts were not found any difference ( Figure   1 ). The IC50 values of cherry laurel extracts could not be calculated by using ELISA data.
The data revealed that all cells were more durable than 5FU to cherry laurel extracts.
Also, the proliferation of the cancerous cells of the cherry laurel extracts treatment was not statistically significant, compared with that of control cells (P > 0.05). It is known that natural products including various metabolites exhibit a strong pharmacological activity due to interact with cell type. Therefore, the antiproliferative activity of cherry laurel extracts mostly consisting of glycosides (amygdalin, prunasin, and sambunigrin)
can be conducted using other type cell lines. Figure 1 . The Antiproliferative activity of cherry laurel extracts and positive control compound, 5FU on HeLa, HT29, C6, and Vero cell lines. Percent inhibition was noted as mean values ± SEM of three independent assays (P < 0.05). Each experiment was repeated at least three times for each cell line. *P < 0.05 in comparison with the control.
Cytotoxic activity of the Prunus laurocerasus extracts
The cytotoxic activity of cherry laurel extracts on HeLa, HT29, C6, and Vero cell lines were tested using an LDH cytotoxicity assay kit and were determined by treating cells with varying concentrations of the cherry laurel extracts (25, 50, 100, 150, 200, 250, 375, and 500 µg/mL), which showed concentration-dependent collapse of cell membrane.
The findings of % cytotoxicity delineate that treatment of cells with higher concentrations of cherry laurel extracts resulted in significant corruption of cell membrane integrity, but its low concentrations did not same effect on the cell membrane ( Figure 2 ). The cell line showed no cytotoxic situations in response to cherry laurel extract treatment up to 375 µg/mL, which confirms that cherry laurel extracts have no cytotoxicity in cells, but it exhibits slightly antiproliferative activity at 375 µg/mL and higher concentrations ( Figure   2 ). Therefore, it is suggested that cherry laurel extracts may have a cytostatic potential towards the cells. Cherry Laurel contains flavonoids like kaempferol and quercetin, and caffeic and coumaric acid along with hydrocyanic acid. Quercetin is known to regulate the expression of apoptosis-related genes and to inhibit lymphocyte tyrosine kinase activity (16) (17) (18) . Quercetin has also been shown to exhibit strong antiproliferative effects towards hepatocarcinoma in vivo experiments (19) . 
Fatty acid analysis
Linoleic acid (18:2), palmitic acid (16:0) and oleic acid (18:1) were detected as fatty acids of hexane extract by GC-MS analysis. The human body cannot synthesize linoleic and oleic acids, both of which play an important role in the life. leading to regulate the blood homeostasis, the immune and inflammation response. In a similar study, main fatty acids constituents of cherry laurel were reported as linoleic, oleic, palmitic and stearic acid (21) which may be attributed to its pharmacological effects. Main ethereal oils (0.5%) of Cherry Laurel were noted as the benzaldehyde, benzyl alcohol, and hydrocyanic acid (22) . Plant oil originated seed or fruit has been used as a healing agent for various diseases. The protective biological activity of cherry laurel extracts is possibly attributed to its high linoleic acid, palmitic acid, and oleic acid contents. It is speculated that these fatty acids may protect DNA, RNA and other macromolecules by modulating oxidative damage in cells (23). On the other hand, these fatty acids use their receptors such as G-protein receptors to exhibit its immunomodulatory effect. However, we should be considered that palmitic acid is generally cytotoxic to cells, whereas oleic acid and linoleic acid are cytoprotective in some certain concentrations in cells (23).
CONCLUSION
In this study, we have displayed biological effects of cherry laurel fruit extracts against HT29, HeLa, C6 and Vero cell lines. The fatty acid-rich bioactive components of cherry laurel fruit extracts that is responsible for the chemoprotective effect. We found that, cherry laurel fruit extracts exhibited considerable protective activity against cell lines at even the highest concentration. Overall, we speculate that cherry laurel fruit extracts could be an important natural source of adjuvant chemotherapeutic formulary.
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